Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
ROSE
|
K2 Principal Fund, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 7,357 Reduced 2.07% |
$58,782
$7.99 p/Share
|
May 07
2018 |
SFNC
|
Jay D Burchfield |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 18.19% |
$599,200
$29.96 p/Share
|
May 07
2018 |
ARE
|
Joel S Marcus
Executive Chairman |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 0.78% |
$642,800
$128.56 p/Share
|
May 07
2018 |
ARE
|
Daniel J Ryan
Co-President and RMD |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 6.01% |
$966,675
$128.89 p/Share
|
May 07
2018 |
ARE
|
Stephen Richardson
Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 7.46% |
$1,290,100
$129.01 p/Share
|
May 07
2018 |
VC
|
Sachin Lawande
CEO and President |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 7.69% |
$312,500
$125.0 p/Share
|
May 07
2018 |
ADI
|
Margaret K Seif
SVP, CPO and CLO |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 22.94% |
$629,020
$89.86 p/Share
|
May 07
2018 |
CRSP
|
Thomas Woiwode
Director |
SELL
Open market or private sale
|
Indirect | 119,709 Reduced 4.08% |
$6,080,020
$50.79 p/Share
|
May 07
2018 |
CRSP
|
Bradley J Ph D Bolzon
Director |
SELL
Open market or private sale
|
Indirect | 119,709 Reduced 4.08% |
$6,080,020
$50.79 p/Share
|
May 07
2018 |
CVX
|
Joseph C Geagea
Executive Vice President |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 90.68% |
$1,536,480
$128.04 p/Share
|
May 07
2018 |
CVX
|
Michael K Wirth
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 130,000 Reduced 100.0% |
$16,640,000
$128.0 p/Share
|
May 07
2018 |
AGLE
|
Novartis Bioventures LTD |
SELL
Open market or private sale
|
Direct | 15,548 Reduced 0.67% |
$157,190
$10.11 p/Share
|
May 07
2018 |
TMUS
|
G Michael Sievert
President and CEO |
SELL
Open market or private sale
|
Direct | 3,056 Reduced 0.65% |
$173,978
$56.93 p/Share
|
May 07
2018 |
AFG
|
S Craig Lindner
Co-CEO |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 0.81% |
$2,211,000
$110.55 p/Share
|
May 07
2018 |
CINF
|
David P Osborn |
BUY
Open market or private purchase
|
Indirect | 370 Added 2.38% |
$25,959
$70.16 p/Share
|
May 07
2018 |
WTM
|
Robert Lawrence Seelig
EVP & General Counsel |
SELL
Open market or private sale
|
Direct | 2,946 Reduced 16.89% |
$2,577,750
$875.0 p/Share
|
May 07
2018 |
TPX
|
Rehan Jaffer
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 180,761 Added 2.36% |
$7,926,370
$43.85 p/Share
|
May 07
2018 |
LAB
|
Levin Capital Strategies, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 44,700 Added 0.4% |
$250,320
$5.6 p/Share
|
May 07
2018 |
JASN
|
Wynnefield Partners Small Cap Value LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 9,432 Added 0.29% |
$24,618
$2.61 p/Share
|
May 07
2018 |
JASN
|
Wynnefield Partners Small Cap Value LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 4,427 Added 0.31% |
$11,554
$2.61 p/Share
|
May 07
2018 |
SUMR
|
Wynnefield Partners Small Cap Value LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 162,231 Added 3.38% |
$129,785
$0.8 p/Share
|
May 07
2018 |
SUMR
|
Wynnefield Partners Small Cap Value LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 76,133 Added 3.63% |
$60,906
$0.8 p/Share
|
May 07
2018 |
HTH
|
Alan B White
Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 18,830 Reduced 8.22% |
$425,746
$22.61 p/Share
|
May 07
2018 |
AMRS
|
Maxwell (Mauritius) Pte LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 95,162 Reduced 2.88% |
$622,359
$6.54 p/Share
|
May 07
2018 |
INSP
|
Orbimed Advisors LLC
Director |
BUY
Open market or private purchase
|
Direct | 312,500 Added 11.34% |
$5,000,000
$16.0 p/Share
|
May 07
2018 |
SIEN
|
Abingworth LLP |
BUY
Open market or private purchase
|
Indirect | 281,482 Added 10.19% |
$3,800,007
$13.5 p/Share
|
May 07
2018 |
RBB
|
Simon Pang |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 12.78% |
$191,590
$27.37 p/Share
|
May 07
2018 |
LAUR
|
Apollo Management Holdings Gp, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 771,536 Reduced 1.74% |
$11,032,965
$14.3 p/Share
|
May 07
2018 |
TZOO
|
Azzurro Capital Inc
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 2,513 Reduced 0.04% |
$32,920
$13.1 p/Share
|
May 04
2018 |
ORCL
|
Thomas Kurian
President-Product Development |
SELL
Open market or private sale
|
Direct | 300,000 Reduced 92.88% |
$13,545,000
$45.15 p/Share
|
May 04
2018 |
MDC
|
David E Blackford
Director |
SELL
Open market or private sale
|
Direct | 2,144 Reduced 16.06% |
$69,701
$32.51 p/Share
|
May 04
2018 |
SMMF
|
Charles Piccirillo
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 2.9% |
$25,690
$25.69 p/Share
|
May 04
2018 |
ARE
|
Joel S Marcus
Executive Chairman |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 1.83% |
$1,534,080
$127.84 p/Share
|
May 04
2018 |
AAPL
|
Angela J Ahrendts
Senior Vice President |
SELL
Open market or private sale
|
Direct | 13,228 Reduced 16.62% |
$2,356,833
$178.17 p/Share
|
May 04
2018 |
LAB
|
Levin Capital Strategies, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 89,800 Added 0.43% |
$510,064
$5.68 p/Share
|
May 04
2018 |
AGFS
|
Dow Du Pont Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3 Added 0.0% |
$21
$6.98 p/Share
|
May 04
2018 |
ADI
|
Peter Real
SVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 4,595 Reduced 25.25% |
$413,550
$90.0 p/Share
|
May 04
2018 |
CVS
|
David W Dorman
Director |
BUY
Open market or private purchase
|
Direct | 24,300 Added 18.85% |
$1,511,946
$62.22 p/Share
|
May 04
2018 |
CVS
|
C David Brown Ii
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 8.99% |
$619,900
$61.99 p/Share
|
May 04
2018 |
SCHW
|
Charles R. Schwab
Co-Chairman |
SELL
Open market or private sale
|
Indirect | 200,000 Reduced 0.23% |
$11,238,000
$56.19 p/Share
|
May 04
2018 |
CZNC
|
Frank G Pellegrino |
BUY
Open market or private purchase
|
Direct | 81 Added 1.17% |
$1,980
$24.44 p/Share
|
May 04
2018 |
AIG
|
Thomas B Leonardi
EVP-Gvt. Affairs & Policy |
BUY
Open market or private purchase
|
Direct | 2,500 Added 50.0% |
$128,875
$51.55 p/Share
|
May 04
2018 |
AIG
|
Douglas M Steenland
Director |
BUY
Open market or private purchase
|
Direct | 4,800 Added 50.0% |
$250,032
$52.09 p/Share
|
May 04
2018 |
TDF
|
City Of London Investment Group PLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 19,200 Reduced 0.51% |
$415,488
$21.64 p/Share
|
May 04
2018 |
LDF
|
City Of London Investment Group PLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 6,941 Reduced 0.81% |
$77,600
$11.18 p/Share
|
May 04
2018 |
KF
|
City Of London Investment Group PLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 9.43% |
$414,700
$41.47 p/Share
|
May 04
2018 |
CFR
|
Graham M Weston
Director |
BUY
Open market or private purchase
|
Indirect | 3,000 Added 0.56% |
$344,100
$114.7 p/Share
|
May 04
2018 |
ARE
|
Lawrence J Diamond
Co-Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 4.91% |
$315,400
$126.16 p/Share
|
May 04
2018 |
KWR
|
Joseph A Berquist
EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 14.38% |
$294,000
$147.0 p/Share
|
May 04
2018 |
EVR
|
Jason Klurfeld
General Counsel |
SELL
Open market or private sale
|
Direct | 717 Reduced 7.1% |
$73,851
$103.0 p/Share
|
May 04
2018 |